Early Cognitive Decline – Eli Lilly I5T-MC-AACV
Experiencing Memory Issues, Communication Challenges, and Decision-Making Problems? Could you be experiencing early signs of Dementia?
Consider a research study for Early Cognitive Decline for you or a loved one.
The Neurology Center of Southern California, along with Profound Research, are enrolling a Dementia study that is assessing Donanemab (Kisunla) to see if it changes cognitive and functional progression.
To be eligible to participate, you must:
- Be 55-85 years of age
- Have gradual and progressive cognitive decline for at least 6 months
- Have a caregiver who is willing to attend all study visits
- If taking symptomatic medication for Alzheimer’s Disease, Dementia with Lewy Bodies, or Parkisonism, medication must be stable for at least 30 days
- Have a life expectancy of at least 2 years
Additional criteria apply.
Qualified participants will receive:
- Study-related care and study medication at no cost
- Financial compensation [up to $XX] for time and travel expenses
Number of visits and duration of study:
- 17 clinic visits over a 60-week time period
Call us at 619-489-5613 or complete the form and our team will reach out soon to help determine your eligibility.
